How much funding has Nour Heart Inc. raised?

Nour Heart Inc. has raised $1.7M in total funding, most recently a Grant round.

Who are Nour Heart Inc.'s investors?

Nour Heart Inc.'s investors include National Institutes of Health.

When was Nour Heart Inc. founded?

Nour Heart Inc. was founded in 2024.

Where is Nour Heart Inc. headquartered?

Nour Heart Inc. is headquartered in Vienna, Virginia, United States.

What industry is Nour Heart Inc. in?

Nour Heart Inc. operates in Biotech, Healthcare.

How many employees does Nour Heart Inc. have?

Nour Heart Inc. has 1-10 employees.

Nour Heart Inc.

Nour Heart, Inc. | Professor Dr. Salwa Ahmed Elgebaly

Vienna, United States · Founded 2024 · $1.7M raised

Biotech

Healthcare

Headquarters: Vienna, Virginia
Employees: 1–10
Founded: 2024
Business Model: B2G

Website: nourheart.com
Total Funding: $1.7M
Last Round: $1.7M GrantSep 2024
Rounds: 1

About

Nour Heart is a biomedical company developing diagnostic and therapeutic products for the early detection and treatment of myocardial ischemia. The company's Nourin® miRNA biomarkers enable early rule-in/rule-out of ischemia in chest pain patients, while Nourexal® is a cardioprotective therapy with applications in heart transplantation and cardiac surgery.

Summary

Nour Heart Inc. is a Biotech company based in Vienna, United States, founded in 2024. It has raised $1.7M in total across 1 round, most recently a $1.7M Grant round in Sep 2024. Investors include National Institutes of Health.